Cumberland Pharmaceuticals Inc earnings per share and revenue
On Nov 04, 2025, CPIX reported earnings of -0.06 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 8.29 million, compared to an expected --, with a --% difference. The market reacted with a -12.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Cumberland Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cumberland Pharmaceuticals Inc reported EPS of -$0.06, missing estimates by --, and revenue of $8.29M, -- -- expectations.
How did the market react to Cumberland Pharmaceuticals Inc's Q3 2025 earnings?
The stock price moved down -12.41%, changed from $2.66 before the earnings release to $2.33 the day after.
When is Cumberland Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for Cumberland Pharmaceuticals Inc's next earnings report?
Based on --
analysts, Cumberland Pharmaceuticals Inc is expected to report EPS of -- and revenue of -- for Q4 2025.